DK154607C - Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider - Google Patents
Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloiderInfo
- Publication number
- DK154607C DK154607C DK529879A DK529879A DK154607C DK 154607 C DK154607 C DK 154607C DK 529879 A DK529879 A DK 529879A DK 529879 A DK529879 A DK 529879A DK 154607 C DK154607 C DK 154607C
- Authority
- DK
- Denmark
- Prior art keywords
- ergotal
- kaloids
- preparing
- procedure
- oral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1302178 | 1978-12-21 | ||
| CH1301978 | 1978-12-21 | ||
| CH1302178 | 1978-12-21 | ||
| CH1301978 | 1978-12-21 | ||
| CH56779 | 1979-01-19 | ||
| CH56679 | 1979-01-19 | ||
| CH56779 | 1979-01-19 | ||
| CH56679 | 1979-01-19 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK529879A DK529879A (da) | 1980-06-22 |
| DK154607B DK154607B (da) | 1988-12-05 |
| DK154607C true DK154607C (da) | 1989-06-05 |
Family
ID=27427929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK529879A DK154607C (da) | 1978-12-21 | 1979-12-12 | Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider |
Country Status (23)
| Country | Link |
|---|---|
| AT (1) | AT372279B (Direct) |
| AU (1) | AU534051B2 (Direct) |
| CA (1) | CA1139222A (Direct) |
| CH (1) | CH642259A5 (Direct) |
| CY (1) | CY1330A (Direct) |
| DE (1) | DE2950154A1 (Direct) |
| DK (1) | DK154607C (Direct) |
| FI (1) | FI793888A7 (Direct) |
| FR (1) | FR2444463A1 (Direct) |
| GB (1) | GB2038181B (Direct) |
| HK (1) | HK37986A (Direct) |
| HU (1) | HU182577B (Direct) |
| IE (1) | IE49323B1 (Direct) |
| IL (1) | IL59003A (Direct) |
| IT (1) | IT1164029B (Direct) |
| KE (1) | KE3617D (Direct) |
| MY (1) | MY8500129A (Direct) |
| NL (1) | NL187229C (Direct) |
| NZ (1) | NZ192457A (Direct) |
| PH (1) | PH25178A (Direct) |
| PT (1) | PT70614A (Direct) |
| SE (1) | SE442265B (Direct) |
| WO (1) | WO1980001242A1 (Direct) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0064485B1 (en) * | 1981-04-27 | 1985-07-24 | Aktiebolaget Hässle | New pharmaceutical preparation |
| US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
| HU192050B (en) * | 1983-04-22 | 1987-05-28 | Sandoz Ag | Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist |
| DE3413955A1 (de) * | 1983-04-22 | 1984-10-25 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten |
| NL194389C (nl) * | 1984-06-14 | 2002-03-04 | Novartis Ag | Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager. |
| GB8426922D0 (en) * | 1984-10-24 | 1984-11-28 | Sandoz Ltd | Galenic formulation |
| AT388101B (de) * | 1985-02-05 | 1989-05-10 | Sandoz Ag | Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung |
| CN1003978B (zh) * | 1987-09-05 | 1989-04-26 | 广州陈李济药厂 | 一种补脾益肠丸的制备工艺 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3432593A (en) * | 1963-09-18 | 1969-03-11 | Key Pharm Inc | Delayed and sustained release type pharmaceutical preparation |
| DE2528257C2 (de) * | 1974-07-04 | 1986-02-13 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue galenische Zubereitung |
| DE2546577B2 (de) * | 1975-10-17 | 1981-04-02 | Sandoz-Patent-GmbH, 7850 Lörrach | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
-
1979
- 1979-12-12 SE SE7910227A patent/SE442265B/sv not_active IP Right Cessation
- 1979-12-12 FI FI793888A patent/FI793888A7/fi not_active Application Discontinuation
- 1979-12-12 DK DK529879A patent/DK154607C/da not_active IP Right Cessation
- 1979-12-12 WO PCT/CH1979/000160 patent/WO1980001242A1/de not_active Ceased
- 1979-12-12 CH CH626380A patent/CH642259A5/de not_active IP Right Cessation
- 1979-12-13 DE DE19792950154 patent/DE2950154A1/de active Granted
- 1979-12-18 NL NLAANVRAGE7909105,A patent/NL187229C/xx not_active IP Right Cessation
- 1979-12-19 CY CY1330A patent/CY1330A/en unknown
- 1979-12-19 IE IE2471/79A patent/IE49323B1/en unknown
- 1979-12-19 IL IL59003A patent/IL59003A/xx unknown
- 1979-12-19 CA CA000342212A patent/CA1139222A/en not_active Expired
- 1979-12-19 NZ NZ192457A patent/NZ192457A/xx unknown
- 1979-12-19 AU AU54031/79A patent/AU534051B2/en not_active Ceased
- 1979-12-19 GB GB7943633A patent/GB2038181B/en not_active Expired
- 1979-12-19 PT PT70614A patent/PT70614A/pt not_active IP Right Cessation
- 1979-12-19 PH PH23436A patent/PH25178A/en unknown
- 1979-12-20 FR FR7931229A patent/FR2444463A1/fr active Granted
- 1979-12-20 AT AT0803679A patent/AT372279B/de active
- 1979-12-20 IT IT51153/79A patent/IT1164029B/it active
- 1979-12-20 HU HU79SA3216A patent/HU182577B/hu not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY129/85A patent/MY8500129A/xx unknown
-
1986
- 1986-03-18 KE KE3617BD patent/KE3617D/xx unknown
- 1986-05-22 HK HK379/86A patent/HK37986A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH642259A5 (de) | 1984-04-13 |
| CA1139222A (en) | 1983-01-11 |
| IT7951153A0 (it) | 1979-12-20 |
| DE2950154A1 (de) | 1980-07-10 |
| FR2444463A1 (fr) | 1980-07-18 |
| MY8500129A (en) | 1985-12-31 |
| DK529879A (da) | 1980-06-22 |
| ATA803679A (de) | 1983-02-15 |
| IL59003A (en) | 1982-12-31 |
| IE792471L (en) | 1980-06-21 |
| IE49323B1 (en) | 1985-09-18 |
| NL7909105A (nl) | 1980-06-24 |
| FI793888A7 (fi) | 1981-01-01 |
| SE7910227L (sv) | 1980-06-22 |
| AT372279B (de) | 1983-09-26 |
| HK37986A (en) | 1986-05-30 |
| SE442265B (sv) | 1985-12-16 |
| DE2950154C2 (Direct) | 1989-05-11 |
| CY1330A (en) | 1986-06-27 |
| GB2038181A (en) | 1980-07-23 |
| NL187229C (nl) | 1991-07-16 |
| KE3617D (en) | 1986-04-18 |
| PH25178A (en) | 1991-03-27 |
| HU182577B (en) | 1984-02-28 |
| AU534051B2 (en) | 1984-01-05 |
| DK154607B (da) | 1988-12-05 |
| AU5403179A (en) | 1980-06-26 |
| PT70614A (fr) | 1980-01-01 |
| IT1164029B (it) | 1987-04-08 |
| WO1980001242A1 (fr) | 1980-06-26 |
| FR2444463B1 (Direct) | 1983-02-25 |
| NZ192457A (en) | 1983-06-17 |
| GB2038181B (en) | 1983-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK153440C (da) | Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat | |
| DK153773C (da) | Fremgangsmaade til fremstillling af et farmaceutisk praeparat til forlaenget frigoerelse af et laegemiddel | |
| DK562276A (da) | Fremgangsmaade til fremstilling af en farmaceutisk administrationsform | |
| RO75336A (ro) | Procedeu pentru prepararea unei forme farmaceutice destinate administrarii transdermale a clonidinei | |
| SE433804B (sv) | Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt | |
| DK162877C (da) | Depotplaster til indgift af et laegemiddel | |
| FI65914B (fi) | Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a | |
| ES503132A0 (es) | Un procedimiento de preparacion de una composicion farmaceu-tica de un esteroide | |
| DK143221C (da) | Fremgangsmaade til fremstilling af et laegemiddel i folieform til oral eller topisk anvendelse | |
| DK664387D0 (da) | Fremgangsmaade til fremstilling af et anti-inflammatorisk farmaceutisk praeparat | |
| DK588476A (da) | Fremgangsmade til fremstilling af et oralt administrerbart farmaceutisk preparat | |
| DK160739C (da) | Fremgangsmaade til fremstilling af et stabilt prostaglandinindeholdende praeparat til laegemiddelanvendelse | |
| DK271677A (da) | Fremgangsmade til fremstilling af et farmaceutisk indsetningspreparat | |
| DK528879A (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende isosorbiddinitrat | |
| DK152173C (da) | Fremgangsmaade til fremstilling af en farmaceutisk zinkkompleksoploesning til oral indgift | |
| DK152333C (da) | Indretning til oral indgivelse til droevtyggere | |
| DK302880A (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende en 3-amino1-aryl-2-pyrazolin | |
| DK645788A (da) | Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat | |
| DK203879A (da) | Fremgangsmaade til fremstilling af en farmaceutisk doseringskomponent | |
| NO146044C (no) | Fremgangsmaate for fremstilling av et farmasoeytisk insulin-preparat for rektal bruk | |
| DK280282A (da) | Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider | |
| DK98076A (da) | Fremgangsmade til fremstilling af et farmaceutisk preparat | |
| DK352578A (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat | |
| DK7679A (da) | Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat | |
| DK159136C (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat til rectal indgivning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |